Clinical trial
Efficacy and Safety of SH T00660AA in Treatment of Endometriosis
NCT00225199 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00225199 |
|---|---|
| Title | Efficacy and Safety of SH T00660AA in Treatment of Endometriosis |
| Official title | A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of Daily Oral Administration of SH T00660AA for the Treatment of Endometriosis Over 12 Weeks |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Endometriosis |
| Intervention type | Drug |
| Interventions | Visanne (BAY86-5258, SH T00660AA), Placebo |
| Enrollment | 198 |
| Start date | Mar 1, 2004 |
| Completion | Sep 1, 2006 |
| First posted | Sep 23, 2005 |
| Last update posted | Apr 23, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: